Literature DB >> 23824835

Integrative variable selection via Bayesian model uncertainty.

M A Quintana1, D V Conti.   

Abstract

We are interested in developing integrative approaches for variable selection problems that incorporate external knowledge on a set of predictors of interest. In particular, we have developed an integrative Bayesian model uncertainty (iBMU) method, which formally incorporates multiple sources of data via a second-stage probit model on the probability that any predictor is associated with the outcome of interest. Using simulations, we demonstrate that iBMU leads to an increase in power to detect true marginal associations over more commonly used variable selection techniques, such as least absolute shrinkage and selection operator and elastic net. In addition, iBMU leads to a more efficient model search algorithm over the basic BMU method even when the predictor-level covariates are only modestly informative. The increase in power and efficiency of our method becomes more substantial as the predictor-level covariates become more informative. Finally, we demonstrate the power and flexibility of iBMU for integrating both gene structure and functional biomarker information into a candidate gene study investigating over 50 genes in the brain reward system and their role with smoking cessation from the Pharmacogenetics of Nicotine Addiction and Treatment Consortium.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Bayes factors; genetic association studies; group variable selection; informative model space prior

Mesh:

Substances:

Year:  2013        PMID: 23824835      PMCID: PMC4085544          DOI: 10.1002/sim.5888

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  28 in total

1.  Using hierarchical modeling in genetic association studies with multiple markers: application to a case-control study of bladder cancer.

Authors:  Rayjean J Hung; Paul Brennan; Christian Malaveille; Stefano Porru; Francesco Donato; Paolo Boffetta; John S Witte
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-06       Impact factor: 4.254

2.  CYP2A6 genotype and the metabolism and disposition kinetics of nicotine.

Authors:  Neal L Benowitz; Gary E Swan; Peyton Jacob; Christina N Lessov-Schlaggar; Rachel F Tyndale
Journal:  Clin Pharmacol Ther       Date:  2006-11       Impact factor: 6.875

3.  Incorporating model uncertainty in detecting rare variants: the Bayesian risk index.

Authors:  Melanie A Quintana; Jonine L Berstein; Duncan C Thomas; David V Conti
Journal:  Genet Epidemiol       Date:  2011-08-26       Impact factor: 2.135

4.  Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials.

Authors:  Caryn Lerman; Christopher Jepson; E Paul Wileyto; Leonard H Epstein; Margaret Rukstalis; Freda Patterson; Vyga Kaufmann; Stephanie Restine; Larry Hawk; Ray Niaura; Wade Berrettini
Journal:  Neuropsychopharmacology       Date:  2006-01       Impact factor: 7.853

5.  Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion.

Authors:  F Patterson; R A Schnoll; E P Wileyto; A Pinto; L H Epstein; P G Shields; L W Hawk; R F Tyndale; N Benowitz; C Lerman
Journal:  Clin Pharmacol Ther       Date:  2008-04-02       Impact factor: 6.875

Review 6.  Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data.

Authors:  Gregory M Cooper; Jay Shendure
Journal:  Nat Rev Genet       Date:  2011-08-18       Impact factor: 53.242

7.  Regularization Paths for Generalized Linear Models via Coordinate Descent.

Authors:  Jerome Friedman; Trevor Hastie; Rob Tibshirani
Journal:  J Stat Softw       Date:  2010       Impact factor: 6.440

8.  CHRNA4 and tobacco dependence: from gene regulation to treatment outcome.

Authors:  Kent E Hutchison; David L Allen; Francesca M Filbey; Christopher Jepson; Caryn Lerman; Neal L Benowitz; Jerry Stitzel; Angela Bryan; John McGeary; Heather M Haughey
Journal:  Arch Gen Psychiatry       Date:  2007-09

9.  The Reactome BioMart.

Authors:  Robin A Haw; David Croft; Christina K Yung; Nelson Ndegwa; Peter D'Eustachio; Henning Hermjakob; Lincoln D Stein
Journal:  Database (Oxford)       Date:  2011-10-19       Impact factor: 3.451

10.  The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases.

Authors:  Ron Caspi; Tomer Altman; Kate Dreher; Carol A Fulcher; Pallavi Subhraveti; Ingrid M Keseler; Anamika Kothari; Markus Krummenacker; Mario Latendresse; Lukas A Mueller; Quang Ong; Suzanne Paley; Anuradha Pujar; Alexander G Shearer; Michael Travers; Deepika Weerasinghe; Peifen Zhang; Peter D Karp
Journal:  Nucleic Acids Res       Date:  2011-11-18       Impact factor: 16.971

View more
  19 in total

Review 1.  Reducing GWAS Complexity.

Authors:  Dennis J Hazelett; David V Conti; Ying Han; Ali Amin Al Olama; Doug Easton; Rosalind A Eeles; Zsofia Kote-Jarai; Christopher A Haiman; Gerhard A Coetzee
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

2.  Fine Mapping Causal Variants with an Approximate Bayesian Method Using Marginal Test Statistics.

Authors:  Wenan Chen; Beth R Larrabee; Inna G Ovsyannikova; Richard B Kennedy; Iana H Haralambieva; Gregory A Poland; Daniel J Schaid
Journal:  Genetics       Date:  2015-05-06       Impact factor: 4.562

3.  Incorporating Functional Annotations for Fine-Mapping Causal Variants in a Bayesian Framework Using Summary Statistics.

Authors:  Wenan Chen; Shannon K McDonnell; Stephen N Thibodeau; Lori S Tillmans; Daniel J Schaid
Journal:  Genetics       Date:  2016-09-21       Impact factor: 4.562

4.  Statistical Methods in Integrative Genomics.

Authors:  Sylvia Richardson; George C Tseng; Wei Sun
Journal:  Annu Rev Stat Appl       Date:  2016-04-18       Impact factor: 5.810

Review 5.  From genome-wide associations to candidate causal variants by statistical fine-mapping.

Authors:  Daniel J Schaid; Wenan Chen; Nicholas B Larson
Journal:  Nat Rev Genet       Date:  2018-08       Impact factor: 53.242

6.  False discovery rates for rare variants from sequenced data.

Authors:  Marinela Capanu; Venkatraman E Seshan
Journal:  Genet Epidemiol       Date:  2014-12-30       Impact factor: 2.135

7.  Bayesian vector autoregressive model for multi-subject effective connectivity inference using multi-modal neuroimaging data.

Authors:  Sharon Chiang; Michele Guindani; Hsiang J Yeh; Zulfi Haneef; John M Stern; Marina Vannucci
Journal:  Hum Brain Mapp       Date:  2016-11-16       Impact factor: 5.038

8.  A Bayesian model for the identification of differentially expressed genes in Daphnia magna exposed to munition pollutants.

Authors:  Alberto Cassese; Michele Guindani; Philipp Antczak; Francesco Falciani; Marina Vannucci
Journal:  Biometrics       Date:  2015-03-13       Impact factor: 2.571

9.  Post hoc Analysis for Detecting Individual Rare Variant Risk Associations Using Probit Regression Bayesian Variable Selection Methods in Case-Control Sequencing Studies.

Authors:  Nicholas B Larson; Shannon McDonnell; Lisa Cannon Albright; Craig Teerlink; Janet Stanford; Elaine A Ostrander; William B Isaacs; Jianfeng Xu; Kathleen A Cooney; Ethan Lange; Johanna Schleutker; John D Carpten; Isaac Powell; Joan Bailey-Wilson; Olivier Cussenot; Geraldine Cancel-Tassin; Graham Giles; Robert MacInnis; Christiane Maier; Alice S Whittemore; Chih-Lin Hsieh; Fredrik Wiklund; William J Catalona; William Foulkes; Diptasri Mandal; Rosalind Eeles; Zsofia Kote-Jarai; Michael J Ackerman; Timothy M Olson; Christopher J Klein; Stephen N Thibodeau; Daniel J Schaid
Journal:  Genet Epidemiol       Date:  2016-06-17       Impact factor: 2.135

10.  Weibull regression with Bayesian variable selection to identify prognostic tumour markers of breast cancer survival.

Authors:  P J Newcombe; H Raza Ali; F M Blows; E Provenzano; P D Pharoah; C Caldas; S Richardson
Journal:  Stat Methods Med Res       Date:  2016-09-30       Impact factor: 3.021

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.